Literature DB >> 26079636

Combined transcranial direct current stimulation and home-based occupational therapy for upper limb motor impairment following intracerebral hemorrhage: a double-blind randomized controlled trial.

Jesper Mortensen1,2, Krystian Figlewski2, Henning Andersen2,3.   

Abstract

PURPOSE: To investigate the combined effect of transcranial direct current stimulation (tDCS) and home-based occupational therapy on activities of daily living (ADL) and grip strength, in patients with upper limb motor impairment following intracerebral hemorrhage (ICH).
METHODS: A double-blind randomized controlled trial with one-week follow-up. Patients received five consecutive days of occupational therapy at home, combined with either anodal (n = 8) or sham (n = 7) tDCS. The primary outcome was ADL performance, which was assessed with the Jebsen-Taylor test (JTT).
RESULTS: Both groups improved JTT over time (p < 0.01). The anodal group improved grip strength compared with the sham group from baseline to post-assessment (p = 0.025). However, this difference was attenuated at one-week follow-up. There was a non-significant tendency for greater improvement in JTT in the anodal group compared with the sham group, from baseline to post-assessment (p = 0.158).
CONCLUSIONS: Five consecutive days of tDCS combined with occupational therapy provided greater improvements in grip strength compared with occupational therapy alone. tDCS is a promising add-on intervention regarding training of upper limb motor impairment. It is well tolerated by patients and can easily be applied for home-based training. Larger studies with long-term follow-up are needed to further explore possible effects of tDCS in patients with ICH. IMPLICATIONS FOR REHABILITATION: Five consecutive days of tDCS combined with occupational therapy provided greater improvements in grip strength compared with occupational therapy alone. tDCS is well tolerated by patients and can easily be applied for home-based rehabilitation.

Entities:  

Keywords:  ADL; home-based intervention; motor impairment; occupational therapy; stroke; tDCS; upper limb

Mesh:

Year:  2015        PMID: 26079636     DOI: 10.3109/09638288.2015.1055379

Source DB:  PubMed          Journal:  Disabil Rehabil        ISSN: 0963-8288            Impact factor:   3.033


  16 in total

Review 1.  Low intensity transcranial electric stimulation: Safety, ethical, legal regulatory and application guidelines.

Authors:  A Antal; I Alekseichuk; M Bikson; J Brockmöller; A R Brunoni; R Chen; L G Cohen; G Dowthwaite; J Ellrich; A Flöel; F Fregni; M S George; R Hamilton; J Haueisen; C S Herrmann; F C Hummel; J P Lefaucheur; D Liebetanz; C K Loo; C D McCaig; C Miniussi; P C Miranda; V Moliadze; M A Nitsche; R Nowak; F Padberg; A Pascual-Leone; W Poppendieck; A Priori; S Rossi; P M Rossini; J Rothwell; M A Rueger; G Ruffini; K Schellhorn; H R Siebner; Y Ugawa; A Wexler; U Ziemann; M Hallett; W Paulus
Journal:  Clin Neurophysiol       Date:  2017-06-19       Impact factor: 3.708

Review 2.  Safety of Transcranial Direct Current Stimulation: Evidence Based Update 2016.

Authors:  Marom Bikson; Pnina Grossman; Chris Thomas; Adantchede Louis Zannou; Jimmy Jiang; Tatheer Adnan; Antonios P Mourdoukoutas; Greg Kronberg; Dennis Truong; Paulo Boggio; André R Brunoni; Leigh Charvet; Felipe Fregni; Brita Fritsch; Bernadette Gillick; Roy H Hamilton; Benjamin M Hampstead; Ryan Jankord; Adam Kirton; Helena Knotkova; David Liebetanz; Anli Liu; Colleen Loo; Michael A Nitsche; Janine Reis; Jessica D Richardson; Alexander Rotenberg; Peter E Turkeltaub; Adam J Woods
Journal:  Brain Stimul       Date:  2016-06-15       Impact factor: 8.955

Review 3.  Recovery and Rehabilitation after Intracerebral Hemorrhage.

Authors:  Michael F Saulle; Heidi M Schambra
Journal:  Semin Neurol       Date:  2016-05-23       Impact factor: 3.420

Review 4.  The Role of Telehealth to Assist In-Home tDCS: Opportunities, Promising Results and Acceptability.

Authors:  Brenton Hordacre
Journal:  Brain Sci       Date:  2018-06-07

Review 5.  Safety Review of Transcranial Direct Current Stimulation in Stroke.

Authors:  Cristina Russo; Maíra I Souza Carneiro; Nadia Bolognini; Felipe Fregni
Journal:  Neuromodulation       Date:  2017-02-21

6.  Evidence-Based Guidelines and Secondary Meta-Analysis for the Use of Transcranial Direct Current Stimulation in Neurological and Psychiatric Disorders.

Authors:  Felipe Fregni; Mirret M El-Hagrassy; Kevin Pacheco-Barrios; Sandra Carvalho; Jorge Leite; Marcel Simis; Jerome Brunelin; Ester Miyuki Nakamura-Palacios; Paola Marangolo; Ganesan Venkatasubramanian; Daniel San-Juan; Wolnei Caumo; Marom Bikson; André R Brunoni
Journal:  Int J Neuropsychopharmacol       Date:  2021-04-21       Impact factor: 5.176

7.  Transcranial direct current stimulation (tDCS) for improving activities of daily living, and physical and cognitive functioning, in people after stroke.

Authors:  Bernhard Elsner; Joachim Kugler; Marcus Pohl; Jan Mehrholz
Journal:  Cochrane Database Syst Rev       Date:  2020-11-11

Review 8.  Opportunities for Guided Multichannel Non-invasive Transcranial Current Stimulation in Poststroke Rehabilitation.

Authors:  Begonya Otal; Anirban Dutta; Águida Foerster; Oscar Ripolles; Amy Kuceyeski; Pedro C Miranda; Dylan J Edwards; Tihomir V Ilić; Michael A Nitsche; Giulio Ruffini
Journal:  Front Neurol       Date:  2016-02-24       Impact factor: 4.003

Review 9.  Transcranial direct current stimulation (tDCS) for improving capacity in activities and arm function after stroke: a network meta-analysis of randomised controlled trials.

Authors:  Bernhard Elsner; Gert Kwakkel; Joachim Kugler; Jan Mehrholz
Journal:  J Neuroeng Rehabil       Date:  2017-09-13       Impact factor: 4.262

10.  Home-based transcranial direct current stimulation plus tracking training therapy in people with stroke: an open-label feasibility study.

Authors:  Ann Van de Winckel; James R Carey; Teresa A Bisson; Elsa C Hauschildt; Christopher D Streib; William K Durfee
Journal:  J Neuroeng Rehabil       Date:  2018-09-18       Impact factor: 4.262

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.